Compounds > 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
Page last updated: 2024-09-04

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Chronic Illness

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione has been researched along with Chronic Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hamed, MS; Kamal, DE; Mostafa, DI; Sarhan, SA1

Other Studies

1 other study(ies) available for 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Chronic Illness

ArticleYear
Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients.
    Clinical rheumatology, 2022, Volume: 41, Issue:10

    Topics: Arthritis, Rheumatoid; Chronic Disease; Humans; Mitoxantrone; Psychometrics; Quality of Life; Reproducibility of Results; Self Efficacy; Surveys and Questionnaires

2022